US Patent

US11844858 — Aqueous ophthalmic solutions of phentolamine and medical uses thereof

Formulation · Assigned to Ocuphire Pharma Inc · Expires 2034-01-31 · 8y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects aqueous ophthalmic solutions of phentolamine or its pharmaceutically acceptable salts, including phentolamine mesylate.

USPTO Abstract

The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.

Drugs covered by this patent

Patent Metadata

Patent number
US11844858
Jurisdiction
US
Classification
Formulation
Expires
2034-01-31
Drug substance claim
No
Drug product claim
Yes
Assignee
Ocuphire Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.